Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
Date
2021-07Author
Morschhauser, F
Dyer, MJS
Walter, HS
Danilov, AV
Ysebaert, L
Hodson, DJ
Fegan, C
Rule, Simon
Radford, J
Cartron, G
Bouabdallah, K
Davies, AJ
Spurgeon, S
Rajakumaraswamy, N
Li, B
Humeniuk, R
Huang, X
Bhargava, P
Jürgensmeier, JM
Salles, G
Subject
Adult Aged Antineoplastic Agents Female Humans Imidazoles Indazoles Lymphoma, B-Cell Male Middle Aged Protein Kinase Inhibitors Purines Pyrazines Pyrimidines Quinazolinones
Metadata
Show full item recordCollections
Publisher
Springer Nature [academic journals on nature.com]
Place of Publication
England
Journal
Leukemia
Volume
35
Issue
7
Pagination
2108-2113
Author URL
Recommended, similar items
The following license files are associated with this item: